This review provides a comprehensive framework for understanding how core metabolic pathways—glycolysis, the TCA cycle, oxidative phosphorylation, fatty acid oxidation, and amino acid metabolism—are rewired during macrophage polarization under the orchestration of upstream signaling cascades, including NF‐κB, PI3K/AKT/mTOR, JAK–STAT, and MAPK.
Abstract
Macrophages orchestrate immune responses through remarkable phenotypic plasticity, which is intrinsically linked to their ability to reprogram intracellular metabolic pathways in response to microenvironmental cues. While recent advances have highlighted the role of aberrant macrophage metabolism in diverse diseases, a systematic synthesis integrating both intracellular and extracellular metabolic signals remains lacking. This review provides a comprehensive framework for understanding how core metabolic pathways—glycolysis, the TCA cycle, oxidative phosphorylation (OXPHOS), fatty acid oxidation (FAO), and amino acid metabolism—are rewired during macrophage polarization under the orchestration of upstream signaling cascades, including NF‐κB, PI3K/AKT/mTOR, JAK–STAT, and MAPK. We examine how exogenous metabolites such as succinate, itaconate, lactate, and amino acids reciprocally regulate macrophage function and discuss tissue‐specific metabolic signatures of macrophage subsets—including alveolar macrophages (AMs), Kupffer cells (KCs), and tumor‐associated macrophages (TAMs)—in the context of obesity, Type 2 diabetes (T2D), metabolic dysfunction‐associated steatotic liver disease (MASLD), infections, autoimmune disorders, and cancer. We further evaluate emerging therapeutic strategies targeting macrophage metabolism, summarizing preclinical and clinical advances across signaling pathways, metabolic nodes, cytokines, and cell‐based therapies with detailed trial data. By integrating cell‐intrinsic metabolic circuitry with extracellular signals, this review establishes a theoretical foundation for metabolism‐targeted immunotherapies and identifies key knowledge gaps for future investigation.
Macrophages adapt to hanging tissue environments by rewiring cellular metabolism, and these metabolic programs actively instruct immune functions rather than merely supplying energy. Across health and disease, shifts in glycolysis, mitochondrial oxidative phosphorylation, lipid handling, and amino acid utilization shap...
Jia-Wei He, Bo-Wen Wang, En-Ze Lei et al.· Frontiers in Immunology· 0 citations
In summary, in-depth elucidation of the molecular mechanisms underlying macrophage metabolic reprogramming and their metabolic crosstalk with breast cancer cells will provide new insights and novel therapeutic targets for the precise immunometabolic therapy of breast cancer.
Jiao-Yu Zhang, Ru-Yu-Wang-Hsin-Ti Yang· Cancer Treatment and Researc...· 0 citations
Hepatic metabolic disorders, characterized by disrupted glucose and lipid homeostasis, are growing global health concerns. While hepatocytes have traditionally been regarded as the primary regulators of metabolic balance, increasing evidence identifies liver macrophages as key mediators that link inflammatory signali...
The activation, differentiation, effector functions, and memory formation of immune cells are not only regulated by signaling pathways and transcription factors but also profoundly depend on the dynamic reprogramming of their intrinsic metabolic states. Over the past decade, groundbreaking research in the field of immu...
Cellular metabolism actively shapes immune cell fate, function, and lineage commitment through coordinated metabolic reprogramming, rather than serving merely as a passive energy supply. Distinct metabolic pathways, including glycolysis, mitochondrial respiration, fatty acid oxidation, and amino acid catabolism, govern...
Liver fibrosis is a dynamic and potentially reversible consequence of chronic liver injury, shaped by persistent inflammation, metabolic disturbance, and impaired tissue repair. Accumulating evidence indicates that, rather than operating as independent processes, immune activation, metabolic reprogramming, and cellular...
Ya-Xuan Cao, Yan Chen, K. Tam· Clinical science· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.